173 related articles for article (PubMed ID: 36146568)
1. Microneedle Delivery of an Adjuvanted Microparticulate Vaccine Induces High Antibody Levels in Mice Vaccinated against Coronavirus.
Vijayanand S; Patil S; Joshi D; Menon I; Braz Gomes K; Kale A; Bagwe P; Yacoub S; Uddin MN; D'Souza MJ
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146568
[TBL] [Abstract][Full Text] [Related]
2. An Adjuvanted Inactivated SARS-CoV-2 Microparticulate Vaccine Delivered Using Microneedles Induces a Robust Immune Response in Vaccinated Mice.
Vijayanand S; Patil S; Menon I; Braz Gomes K; Kale A; Bagwe P; Uddin MN; Zughaier SM; D'Souza MJ
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986756
[TBL] [Abstract][Full Text] [Related]
3. Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration.
Kale A; Joshi D; Menon I; Bagwe P; Patil S; Vijayanand S; Braz Gomes K; D'Souza M
Int J Pharm; 2022 Aug; 624():121975. PubMed ID: 35787459
[TBL] [Abstract][Full Text] [Related]
4. Subunit microparticulate vaccine delivery using microneedles trigger significant SARS-spike-specific humoral and cellular responses in a preclinical murine model.
Patil S; Vijayanand S; Joshi D; Menon I; Braz Gomes K; Kale A; Bagwe P; Yacoub S; Uddin MN; D'Souza MJ
Int J Pharm; 2023 Feb; 632():122583. PubMed ID: 36610521
[TBL] [Abstract][Full Text] [Related]
5. Adjuvanted-SARS-CoV-2 Spike Protein-Based Microparticulate Vaccine Delivered by Dissolving Microneedles Induces Humoral, Mucosal, and Cellular Immune Responses in Mice.
Patil S; Vijayanand S; Menon I; Gomes KB; Kale A; Bagwe P; Yacoub S; Uddin MN; D'Souza MJ
Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631046
[TBL] [Abstract][Full Text] [Related]
6. The Autoinducer N-Octanoyl-L-Homoserine Lactone (C8-HSL) as a Potential Adjuvant in Vaccine Formulations.
Shah SM; Joshi D; Chbib C; Roni MA; Uddin MN
Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242496
[TBL] [Abstract][Full Text] [Related]
7. Gonococcal microparticle vaccine in dissolving microneedles induced immunity and enhanced bacterial clearance in infected mice.
Bagwe P; Bajaj L; Menon I; Braz Gomes K; Kale A; Patil S; Vijayanand S; Gala R; D'Souza MJ; Zughaier SM
Int J Pharm; 2023 Jul; 642():123182. PubMed ID: 37369287
[TBL] [Abstract][Full Text] [Related]
8. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation.
Wang Q; Tan MT; Keegan BP; Barry MA; Heffernan MJ
Biomaterials; 2014 Sep; 35(29):8385-93. PubMed ID: 24986256
[TBL] [Abstract][Full Text] [Related]
9. Novel ablative laser mediated transdermal immunization for microparticulate measles vaccine.
Joshi D; Gala RP; Uddin MN; D'Souza MJ
Int J Pharm; 2021 Sep; 606():120882. PubMed ID: 34298102
[TBL] [Abstract][Full Text] [Related]
10. Poly-(lactic-co-glycolic-acid)-based particulate vaccines: particle uptake by dendritic cells is a key parameter for immune activation.
Silva AL; Rosalia RA; Varypataki E; Sibuea S; Ossendorp F; Jiskoot W
Vaccine; 2015 Feb; 33(7):847-54. PubMed ID: 25576216
[TBL] [Abstract][Full Text] [Related]
11. Zika Vaccine Microparticles (MPs)-Loaded Dissolving Microneedles (MNs) Elicit a Significant Immune Response in a Pre-Clinical Murine Model.
Kale A; Joshi D; Menon I; Bagwe P; Patil S; Vijayanand S; Braz Gomes K; Uddin MN; D'Souza MJ
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992167
[TBL] [Abstract][Full Text] [Related]
12. Assessment of In Vitro Immunostimulatory Activity of an Adjuvanted Whole-Cell Inactivated
Bagwe P; Bajaj L; Gala RP; D'Souza MJ; Zughaier SM
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891147
[TBL] [Abstract][Full Text] [Related]
13. Harnessing T-cell activity against prostate cancer: A therapeutic microparticulate oral cancer vaccine.
Parenky AC; Akalkotkar A; Mulla NS; D'Souza MJ
Vaccine; 2019 Sep; 37(41):6085-6092. PubMed ID: 31477437
[TBL] [Abstract][Full Text] [Related]
14. Novel Whole-Cell Inactivated
Gala RP; Zaman RU; D'Souza MJ; Zughaier SM
Vaccines (Basel); 2018 Sep; 6(3):. PubMed ID: 30181504
[No Abstract] [Full Text] [Related]
15. Co-encapsulated CpG oligodeoxynucleotides and ovalbumin in PLGA microparticles; an in vitro and in vivo study.
San Román B; Gómez S; Irache JM; Espuelas S
J Pharm Pharm Sci; 2014; 17(4):541-53. PubMed ID: 25579433
[TBL] [Abstract][Full Text] [Related]
16. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
[TBL] [Abstract][Full Text] [Related]
17. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Microparticulate (S)-4,5-Dihydroxy-2,3-pentanedione (DPD) as a Potential Vaccine Adjuvant.
Joshi D; Chbib C; Uddin MN; D'Souza MJ
AAPS J; 2021 Jun; 23(4):84. PubMed ID: 34131810
[TBL] [Abstract][Full Text] [Related]
19. A novel microparticulate vaccine for melanoma cancer using transdermal delivery.
Bhowmik T; D'Souza B; Shashidharamurthy R; Oettinger C; Selvaraj P; D'Souza MJ
J Microencapsul; 2011; 28(4):294-300. PubMed ID: 21545320
[TBL] [Abstract][Full Text] [Related]
20. Mucosal application of cationic poly(D,L-lactide-co-glycolide) microparticles as carriers of DNA vaccine and adjuvants to protect chickens against infectious bursal disease.
Negash T; Liman M; Rautenschlein S
Vaccine; 2013 Aug; 31(36):3656-62. PubMed ID: 23777953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
